Apoha develops AI-enabled molecular measurement technology for industries that rely on how matter behaves, particularly pharmaceuticals, biotechnology, food and beverages. Its platform, described as Liquid State Intelligence, captures behavioural “state” data from small samples by measuring interfacial responses and turning them into high-dimensional signatures. For pharma and biotech teams, Apoha supports antibody developability screening, candidate triage, formulation optimisation and protein quality monitoring. For food and beverage innovators, it helps predict sensory performance, compare formulations, benchmark competitors and accelerate product development.
